FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps

TUESDAY, Sept. 20, 2022 (HealthDay News) -- The U.S. Food and Drug Administration is warning patients who use a particular insulin pump system that unauthorized people could access it and change how much insulin a patient receives.

The pump at the center of the FDA alert is the Medtronic MiniMed 600 Series Insulin Pump System, including models such as MiniMed 630G and MiniMed 670G.

Trending Recipe Videos

Originally published on consumer.healthday.com, part of the TownNews Content Exchange.